UA97355C2 - Фармацевтическая композиция, включающая монтелукаст - Google Patents

Фармацевтическая композиция, включающая монтелукаст

Info

Publication number
UA97355C2
UA97355C2 UAA200809892A UAA200809892A UA97355C2 UA 97355 C2 UA97355 C2 UA 97355C2 UA A200809892 A UAA200809892 A UA A200809892A UA A200809892 A UAA200809892 A UA A200809892A UA 97355 C2 UA97355 C2 UA 97355C2
Authority
UA
Ukraine
Prior art keywords
pharmaceutical composition
composition containing
montelukast
containing montelukast
active ingredient
Prior art date
Application number
UAA200809892A
Other languages
English (en)
Ukrainian (uk)
Inventor
Весна Крошельй
Рената Осолник
Турк Урска
Берек Франчи
Original Assignee
Крка, Товарна Здравил, Д.Д., Ново Место
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Крка, Товарна Здравил, Д.Д., Ново Место filed Critical Крка, Товарна Здравил, Д.Д., Ново Место
Priority claimed from PCT/EP2006/070045 external-priority patent/WO2007077135A1/en
Publication of UA97355C2 publication Critical patent/UA97355C2/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

Изобретение относится к фармацевтике и касается фармацевтической композиции, включающей фармацевтически приемлемую соль монтелукаста в виде частичек, имеющих значение d, меньше чем 250 мкм, способа ее получения и фармацевтической композиции в форме пилюли, которую получают прямым прессованием.
UAA200809892A 2005-12-30 2006-12-20 Фармацевтическая композиция, включающая монтелукаст UA97355C2 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP05113112A EP1803457A1 (en) 2005-12-30 2005-12-30 Pharmaceutical composition containing montelukast
PCT/EP2006/070045 WO2007077135A1 (en) 2005-12-30 2006-12-20 Pharmaceutical composition containing montelukast

Publications (1)

Publication Number Publication Date
UA97355C2 true UA97355C2 (ru) 2012-02-10

Family

ID=35658888

Family Applications (1)

Application Number Title Priority Date Filing Date
UAA200809892A UA97355C2 (ru) 2005-12-30 2006-12-20 Фармацевтическая композиция, включающая монтелукаст

Country Status (3)

Country Link
EP (1) EP1803457A1 (ru)
NO (1) NO20083213L (ru)
UA (1) UA97355C2 (ru)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2635841A1 (en) * 2006-02-09 2007-08-16 Teva Pharmaceutical Industries Ltd. Stable pharmaceutical formulations of montelukast sodium
CN101732268B (zh) * 2010-01-09 2012-12-05 鲁南制药集团股份有限公司 一种孟鲁司特钠片剂及其制备方法
KR101445671B1 (ko) * 2010-02-26 2014-09-29 도레이 카부시키가이샤 피복 고형 제제
CN108888602B (zh) * 2018-08-16 2021-04-06 海南锦瑞制药有限公司 一种孟鲁司特钠制剂及其制备方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK1283036T3 (da) * 1998-11-13 2008-03-25 Jagotec Ag Törpulver til inhalation
CA2477260C (en) * 2002-03-12 2009-05-19 Microdose Technologies, Inc. Site specific delivery of co-administered drugs via inhalation
GB0312148D0 (en) * 2003-05-28 2003-07-02 Aventis Pharma Ltd Stabilized pharmaceutical products
AU2004283832B2 (en) * 2003-10-10 2011-04-07 Synthon B.V. Solid-state montelukast
GB0326632D0 (en) * 2003-11-14 2003-12-17 Jagotec Ag Dry powder formulations
CA2554572A1 (en) * 2004-01-30 2005-08-18 Teva Pharmaceutical Industries Ltd. Montelukast free acid polymorphs

Also Published As

Publication number Publication date
EP1803457A1 (en) 2007-07-04
NO20083213L (no) 2008-09-26

Similar Documents

Publication Publication Date Title
MY144992A (en) Substituted 1,2,3,4-tetrahydroisoquinoline derivatives.
PH12013502277A1 (en) Modified release of 4-methyl-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]-n-5-(4 methyl-1h-imidazol-1-yl)-3-(trifluoromethyl)phenyl] benzamide solubilized using organic acids
EA201001852A1 (ru) Твердые фармацевтические составы, содержащие bibw 2992
MY159208A (en) A novel formulation of indomethacin
NZ595987A (en) A novel formulation of diclofenac
UA103179C2 (ru) Фармацевтическая композиция, которая содержит эзетимиб
IL188942A0 (en) Benzimidazole derivatives and pharmaceutical compositions containing the same
TNSN07337A1 (en) Pharmaceutical composition comprising an indolylmaleimide derivative
TW201129386A (en) Microcrystalline cellulose and calcium phosphate compositions useful as pharmaceutical excipients
ATE488225T1 (de) Kaubare, lutschbare und verschluckbare tablette mit einer calciumhaltigen verbindung als wirkstoff
WO2010097243A3 (en) Process for forming solid oral dosage forms of solifenacin and its pharmaceutically acceptable salts
CA2535013A1 (en) Micro-particle fatty acid salt solid dosage formulations for therapeutic agents
WO2008062475A3 (en) Pharmaceutical compositions of ursodiol
CA2490335A1 (en) Pharmaceutical composition as solid dosage form and method for manufacturing thereof
PL408608A1 (pl) Trwała stała kompozycja farmaceutyczna cytyzyny oraz sposób jej wytwarzania
MA37524A1 (fr) Procedes de production de chlorhydrate d'anamoreline presentant une teneur en chlorure regulee
WO2007110765A3 (en) Processes for the preparation of octreotide
IN2013MU01177A (ru)
UA96575C2 (en) Process for the preparation of olmesartan medoxomil
WO2005079759A3 (en) Pharmaceutical composition for oral application and method for preparing thereof
SI1853232T1 (sl) Stabilna kristalna oblika bifeprunoks-mezilata, njegove dozirne oblike in postopki za njihovo uporabo
EA201001108A1 (ru) Диспергируемые во рту таблетки, содержащие основание эсциталопрама, и способ их получения
NO20083213L (no) Farmasoytisk sammensetning inneholdende montelukast
EA201170583A1 (ru) Новая композиция для лечения эссенциальной тромбоцитемии
TW200727892A (en) Formulations of suberoylanilide hydroxamic acid and methods for producing same